* If you want to update the article please login/register
About 10% of people infected with severe acute respiratory syndrome coronavirus 2 have a post COVID-19 disease. We analyzed results from 968 adult patients with a confirmed infection enrolled in the ComPaRe long COVID study, a disease-free prospective e-cohort of such patients in France. From patients' responses to the Long COVID Symptom Tool, a standardized self-reported questionnaire assessing 53 symptoms, the prevalence of post COVID-19 signs was determined day by day. Patients were still symptomatic after 2 months, and 85 percent of patients who were sick after 2 months developed symptoms one year after the symptom onset.
Source link: https://doi.org/10.1038/s41467-022-29513-z
In some COVID-19 patients, symptoms persist for several weeks, and occasionally, after the acute disease course, these patients experience new signs, which leads to a change to the so-called long COVID. In this report, Google Trends survey was used to monitor public understanding for long COVID and other common signs during the COVID-19 pandemic. Relevant symptoms for COVID-19 or long COVID, for example ageusia and anosmia, are only starting to be more prominent during the pandemic.
Source link: https://doi.org/10.1016/j.bbih.2022.100455
The chronic illness following the COVID-19 disease, which affects between 10 to 25% of patients, has many mechanisms by which the COVID-19 infection may lead to neurological changes and structural and functional changes in the brain, as well as cognitive impairments. The COVID and Cognition Study is a cross-sectional/longitudinal research aimed at investigating cognitive difficulties in Long COVID. The study's first paper reviewed the characteristics of our sample of 181 individuals who had experienced the COVID-19 disease and 185 that did not, as well as the causes that predicted persistent symptoms and self-reported cognitive deficits. We suspect that "objective" cognitive assessments will reveal self-reported cognitive dysfunction. Cognitive impairments were predicting of cognitive function in the first illness and continuing neurological disorders.
Source link: https://doi.org/10.3389/fnagi.2022.804937
Several mechanisms by which COVID-19 infection may lead to neurological problems and structural and functional changes in the brain, and it is likely that several of these will progress into cognitive difficulties. Indeed, cognitive difficulties are one of the most common medical signs in those suffering "Long COVID"-the chronic disease that affects between ten percent of patients. The COVID and Cognition Study is part cross-sectional, part longitudinal, research analyzing, and aiming to recognize Long COVID's cognitive deficits. The severity of initial illness is a good predictor of ongoing symptoms, and it is likely that some signs of the initial illness, particularly leg weakness, are more prevalent in those with more chronic ongoing conditions. The first findings from this first analysis show that the presence and severity of persistent illnesses can be a good predictor of ongoing disease, as well as leg weakness.
Source link: https://doi.org/10.3389/fnagi.2022.804922
Multiple impulsive change demands in work can be a point of acute strain for office workers, with repercussions on health and quality of life. This long-term prospective research sought to investigate the effects of adaptation pressures on a large population of employees of a major Italian banking company in the job-related stress framework. In Reopening's first lockdown, we conducted a web-based questionnaire to 1,264 participants, aged from June to October 2020, corresponding to the rise of contagions from November 2020 to January 2021, and 491 people in the Vaccination Round, which ranged from February to June 2021. We investigated workaholism by using the Dutch Work Addiction Scale, work-family conflicts that can be related by using the Work and Family Conflict Scale, and questions regarding back to work and HW were addressed by specific questions.
Source link: https://doi.org/10.3389/fpsyg.2022.843095
The cyanosis occurred in almost 22 months for a 59-year-old obese man with suspected COVID-19 who suffered painful cyanosis with histopathologic capillary thrombosis of toes. The distal toe 16 weeks after the initial exposure to papillary dermal thrombosis with endothelial swelling, telangiectasia, and peri-eccrine lymphocytic infiltrates resembling pernio were discovered, biopsy of the distal toe. Overall, this is the first case of biopsy of "long COVID toe" following suspected SARS-Cov-2 exposure, with signs of thrombotic vasculopathy, toe cyanosis, and pernio-like pathology.
Source link: https://doi.org/10.1111/cup.14240
More specifically, SO42- dramatically decreased and NO3- dramatically increased over downwind locations like western Japan due to a more rapid reduction of SO2 emissions than NOx emissions and a seemingly constant pattern of NH3 emissions from China. After which China's economic situation started to improve going into 2021, emissions from China plummeted during COVID-19 lockdowns in February-March 2020. The status of Chinese emissions during COVID-19 did not reveal this returning impact in 2021, according to numerical simulations. The status of Chinese emissions in 2021 has improved to that before COVID-19, according to this report.
Source link: https://doi.org/10.1038/s41598-022-09388-2
We're already seeing a growing disparity between those who suffer long-term effects of COVID-19, also known as 'Long COVID-19'. Long COVID-19 so far: What we know about the treatment for Long COVID-19 so far is that it is messy, requires a multidisciplinary approach, and more study is still needed to fully understand the effects.
Source link: https://doi.org/10.1136/medethics-2021-107436
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions